Comparison of the effect of rapeseed oil or amaranth seed oil supplementation on weight loss, body composition and changes in metabolic and metabolomic profile in obese patients following 3-week body mass reduction program: a randomized clinical trial

Not Applicable

• Conditions: E66.0; E78.0; Obesity due to excess calories; Pure hypercholesterolaemia

• Registration Number: DRKS00017708
• Lead Sponsor: Departament of Gastroenterology, Dietetics and Internal Medicine, Karol Marcinkowski University of Medical Sciences, Poznan

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2016-03-01
• Study Start: 2019-08-05
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 308

Inclusion Criteria

BMI equal to or greater than 30 kg /m2,
stable body weight (<3 kg self-reported change during the previous 3 months)

Exclusion Criteria

Exclusion criteria for participation in the study (the presence of even one of the factors):
- being on a vegetarian or any another alternative diet,
- cancer disease (radiotherapy / chemotherapy)
- diabetes mellitus type 1 (T1DM; formerlyinsulin-dependent diabetes or juvenile diabetes)
- liver diseases, kidney disease, pancreas diseases, acute coronary artery disease
- transplantation or implantation surgery (bypass)
- myocardial infarction, ischemic stroke or hemorrhagic stroke
- phenylketonuria, galactosemia
- autoimmune diseases (autoimmune thyroid disease, celiac disease, haemolytic anemia, vitiligo, Addison's disease, hyperbilirubinemia)
- inflammatory bowel disease (Crohn's disease, ulcerative colitis)
- pregnancy
- mental disorders, eating disorders, ie. anorexia, bulimia
- antibiotics, steroids
- addiction to drugs, alcohol (consumption of more than 1 serving of alcohol per day)

Study & Design

• Study Type: interventional
• Study Design: Not specified